PolyPeptide Group is a leading international good manufacturing practice (GMP) peptide manufacturer, operating six production sites worldwide. Our cutting-edge technology ensures the production of high-quality peptides with precision, efficiency, and full compliance with GMP standards. We support pharmaceutical and biotech companies at every stage, from early development to commercial supply, helping bring innovative peptide-based therapeutics and diagnostics to market.
As the demand for peptide-based drugs continues to grow, agile and flexible manufacturing has become critical. PolyPeptide Group’s global production network enables us to rapidly adjust to shifting market needs, whether it be small-scale clinical trial batches or large-scale commercial supply.
Our flexible production approach allows for rapid scale-up, accommodating everything from early-stage development batches to full-scale commercial production. This ensures a seamless transition from research to market, reducing time-to-market for new peptide-based therapies. With a manufacturing infrastructure that can adapt quickly to production demands, we provide a stable and reliable supply chain that pharmaceutical and biotech companies can depend on.
By leveraging advanced synthesis platforms and automation, we optimise processes to improve efficiency and ensure cost-effective production. Our dedicated teams of experts continually enhance process development, optimising yield, purity, and consistency while maintaining full regulatory compliance.
Complex peptide manufacturing for commercial production
PolyPeptide Group has been at the forefront of peptide manufacturing for decades, pioneering innovative synthesis techniques that allow us to produce highly complex peptides at a commercial scale.
Our expertise extends to:
- Long peptides: Optimised strategies for the synthesis of long and challenging sequences with high purity.
- Cyclic peptides: Specialised techniques for head-to-tail cyclisation and disulfide bond formation to enhance peptide stability and activity.
- Peptide conjugates: Conjugation of peptides with other molecules such as lipids, carbohydrates, or carrier proteins for improved therapeutic properties.
Our deep understanding of peptide chemistry allows us to overcome challenges associated with solubility, stability, and aggregation, ensuring high-yield, high-purity peptides suitable for pharmaceutical applications. We work closely with our partners to develop custom peptide solutions, tailoring manufacturing processes to meet specific formulation and regulatory requirements.
Full compliance with pharmaceutical regulatory standards
PolyPeptide Group is fully committed to meeting the highest GMP and regulatory standards, ensuring that our peptides are manufactured under strict quality control protocols. Each of our six global production sites adheres to internationally recognised GMP guidelines, ensuring batch-to-batch consistency, purity, and safety.
Our regulatory expertise spans multiple regions, including the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global regulatory bodies. We provide comprehensive documentation and regulatory support, simplifying the approval process for our customers and ensuring compliance with industry standards.
From early-phase clinical trials to commercial-scale production, we offer full traceability and rigorous quality assurance throughout the manufacturing process. Our state-of-the-art analytical capabilities ensure that all peptides meet the most stringent pharmaceutical and biotech industry specifications.
Up-to-date peptide manufacturing practice and infrastructure
Innovation in peptide manufacturing is critical to advancing drug development and commercialisation. At PolyPeptide Group, we continuously invest in cutting-edge peptide synthesis technologies, automation, and process optimisation to enhance efficiency, scalability, and cost-effectiveness.
Global Reach, local expertise we are an international peptide manufacturer, PolyPeptide Group operates across six production sites worldwide, ensuring global reach while maintaining localised expertise. This allows us to serve pharmaceutical and biotech companies across multiple markets, providing efficient logistics, regional regulatory compliance, and market-specific support.
Our global infrastructure enables us to streamline supply chain management, ensuring timely delivery and uninterrupted production. By maintaining manufacturing operations in multiple locations, we provide:
- Risk mitigation through diversified production capabilities.
- Geographic flexibility to meet local regulatory and market demands.
- A responsive and scalable production network to handle varying batch sizes.
Why partner with PolyPeptide Group?
PolyPeptide Group is a trusted partner in peptide drug development and manufacturing, offering a unique combination of experience, expertise, and cutting-edge technology. Our ability to provide custom peptide solutions, GMP-compliant production, and scalable, flexible manufacturing makes us a preferred choice for pharmaceutical and biotech companies worldwide.
By working with us, you gain access to:
- Decades of expertise in peptide synthesis and manufacturing
- GMP-certified production facilities with global regulatory compliance
- Agile manufacturing capabilities that adapt to market demands
- Cutting-edge technology to optimise efficiency and scalability
- A worldwide production network ensuring reliable supply and risk mitigation
At PolyPeptide Group, we are committed to driving innovation in peptide manufacturing while providing the highest quality products and services. Whether you require small-scale development batches or large commercial production, our expertise, technology, and global reach ensure a seamless, efficient, and cost-effective manufacturing process.